ThermoFisher’s most recent trend suggests a bearish bias. One trading opportunity on ThermoFisher is a Bear Call Spread using a strike $500.00 short call and a strike $520.00 long call offers a potential 29.03% return on risk over the next 21 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $500.00 by expiration. The full premium credit of $4.50 would be kept by the premium seller. The risk of $15.50 would be incurred if the stock rose above the $520.00 long call strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for ThermoFisher is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for ThermoFisher is bullish.
The RSI indicator is at 59.14 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for ThermoFisher
Thermo Fisher Scientific, Inc. to Host Earnings Call
Thu, 29 Apr 2021 10:30:00 +0000
NEW YORK, NY / ACCESSWIRE / April 29, 2021 / Thermo Fisher Scientific, Inc. (SAO:TMOS34) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on April 29, 2021 at 8:30 AM Eastern Time.
2 Risky Life-Sciences Stocks to Avoid and 1 to Buy Now
Thu, 29 Apr 2021 10:25:00 +0000
Enthusiasm for life-sciences stocks may be at an all-time high, but it’s easy to lose your shirt when dealing with companies on the cutting edge like Calyxt (NASDAQ: CLXT) and Zymergen (NASDAQ: ZY). Both of these companies have huge potential for growth, but investors probably want to watch them from a safe distance for now. After discussing what to avoid, I’ll also show you why Thermo Fisher Scientific (NYSE: TMO) is one of the best life-sciences stocks you can buy now.
Thermo Fisher Scientific Reports First Quarter 2021 Results
Thu, 29 Apr 2021 10:00:00 +0000
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended April 3, 2021.
Healthcare ETFs on Radar As Q1 Earnings Unfold
Wed, 28 Apr 2021 16:10:04 +0000
Further price movement of the healthcare ETFs depend on earnings releases from some big names like Pfizer (PFE), Merck (MRK), Thermo Fisher (TMO), AbbVie (ABBV), and Gilead Sciences (GILD) that dominate returns.
Medical Products’ Apr 29 Earnings Roster: TMO, BAX & More
Wed, 28 Apr 2021 13:13:01 +0000
The Medical Product companies’ first-quarter results are likely to reflect robust earnings and revenue growth on solid base business recovery.
Follow Us on Facebook